The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Disulfiram for the treatment of cocaine dependence
Abstract
BACKGROUND: Cocaine dependence is a disorder for which no pharmacological treatment of proven efficacy exists, advances in the neurobiology could guide future medication development. OBJECTIVES: To evaluate the efficacy and the acceptability of disulfiram for cocaine dependence. SEARCH STRATEGY: We searched: PubMed, EMBASE, CINAHL (up to January 2008), the Cochrane Central Register of Controlled Trials (CENTRAL-The Cochrane Library, 1, 2009), reference lists of trials, main electronic sources of ongoing trials, conference proceedings. SELECTION CRITERIA: Randomised and controlled clinical trials comparing disulfiram alone or associated with psychosocial intervention with no intervention, placebo, or other pharmacological intervention for the treatment of cocaine dependence. DATA COLLECTION AND ANALYSIS: Three reviewers independently assessed trial quality and extracted data. MAIN RESULTS: Seven studies, 492 participants, met the inclusion criteriaDisulfiram versus placebo: no statistically significant results for dropouts but a trend favouring disulfiram, two studies, 87 participants, RR 0.82 (95% CI 0.66 to 1.03). One more study, 107 participants, favouring disulfiram, was excluded from meta-analysis due high heterogeneity, RR 0.34 (95% CI 0.20 to 0.58). For cocaine use, it was not possible to pool together primary studies, results from single studies showed that, one, out of four comparisons, was in favour of disulfiram (number of weeks abstinence, 20 participants, WMD 4.50 (95% CI 2.93 to 6.07).Disulfiram versus naltrexone: no statistically significant results for dropouts but a trend favouring disulfiram, three studies, 131 participants, RR 0.67 (95% CI 0.45 to 1.01). No significant difference for cocaine use was seen in the only study that considered this outcome.Disulfiram versus no pharmacological treatment: for cocaine use: a statistically significant difference in favour of disulfiram, one study, two comparisons, 90 participants: maximum weeks of consecutive abstinence, WMD 2.10 (95% CI 0.69 to 3.51); number of subjects achieving 3 or more weeks of consecutive abstinence, RR 1.88 (95% CI 1.09 to 3.23). AUTHORS' CONCLUSIONS: There is low evidence, at the present, supporting the clinical use of disulfiram for the treatment of cocaine dependence. Larger randomised investigations are needed investigating relevant outcomes and reporting data to allow comparisons of results between studies. Results from ongoing studies will be added as soon as their results will be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders
Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003023.pub2 · Cited by 178
RetractedAntidepressants for cocaine dependence
de Lima, M. S., Farrell, M., Reisser, A. A. L., & Soares, B. G. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002950 · Cited by 93
RetractedDopamine agonists for cocaine dependence
Soares, B. G., Reisser, A. A. L., Farrell, M., & de Lima, M. S. (2003) · doi:10.1002/14651858.cd003352 · Cited by 83
RetractedAnticonvulsants for cocaine dependence
Minozzi, S., Amato, L., Davoli, M., Farrell, M., Reisser, A. A. L., Pani, P. P., de Lima, M. S., Soares, B. G., & Vecchi, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006754.pub2 · Cited by 56
Self-citationRetractedHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Self-citationSULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
The addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Degenhardt, L., Chiu, W.-T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Bruffaerts, R., de Girolamo, G., Gureje, O., Huang, Y., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050141 · Cited by 796
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Self-citationEnsuring balanced distribution of prognostic factors in treatment outcome research.
Stout, R. L., Wirtz, P. W., Carbonari, J. P., & Del Boca, F. K. (1994) · Journal of Studies on Alcohol, Supplement · doi:10.15288/jsas.1994.s12.70 · Cited by 461
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414
Methadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
Goodman, L., & Gilman, A. (1941) · AJN, American Journal of Nursing · doi:10.1097/00000446-194109000-00048 · Cited by 402
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
Carroll, K. M., Nich, C., Ball, S. A., Mccance, E., & Rounsavile, B. J. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357137.x · Cited by 375
Disulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
Carroll, K. M., Nich, C., Ball, S. A., McCance, E., Frankforter, T. L., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.95913355.x · Cited by 216
Benzodiazepines for alcohol withdrawal
Ntais, C., Pakos, E., Kyzas, P., & Ioannidis, J. P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063.pub2 · Cited by 206
George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00310-8 · Cited by 159
Anticonvulsants for cocaine dependence
Minozzi, S., Cinquini, M., Amato, L., Davoli, M., Farrell, M., Pani, P. P., & Vecchi, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006754.pub4 · Cited by 141
Self-citationSchank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129
Topp, L., Day, C., & Degenhardt, L. J. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00013-9 · Cited by 128
Antipsychotic medications for cocaine dependence
Indave, B. I., Minozzi, S., Pani, P. P., & Amato, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006306.pub3 · Cited by 122
Self-citationPET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122
Pantalon, M. V., Nich, C., Frankforter, T. L., & Carroll, K. M. (2002) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.16.4.299 · Cited by 115
Disulfiram effects on acute cocaine administration
McCance‐Katz, E. F., Kosten, T. R., & Jatlow, P. L. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00050-7 · Cited by 106
Characteristics and Pretreatment Behaviors of Clients Entering Drug Abuse Treatment: 1969 to 1993
Craddock, S. G., Rounds‐Bryant, J. L., Flynn, P. M., & Hubbard, R. L. (1997) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999709001686 · Cited by 105
Wiglesworth, J. (1886) · Journal of Mental Science · doi:10.1192/bjp.32.137.50 · Cited by 103
Pharmacotherapy and other treatments for cocaine abuse and dependence
Vocci, F. J., & Elkashef, A. M. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165596.98552.02 · Cited by 102
Emerging pharmacological strategies in the fight against cocaine addiction
Sofuoglu, M., & Kosten, T. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.1.91 · Cited by 101
Bourdélat-Parks, B. N., Anderson, G. M., Donaldson, Z. R., Weiss, J. M., Bonsall, R. W., Emery, M., Liles, L. C., & Weinshenker, D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0139-8 · Cited by 97
Pettinati, H. M., Kampman, K. M., Lynch, K. G., Xie, H., Dackis, C., Rabinowitz, A. R., & O′Brien, C. P. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.11.011 · Cited by 95
REVIEW: New developments in the pharmacotherapy of cocaine abuse
Preti, A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00061.x · Cited by 91
Carroll, K. M., Ziedonis, D. M., O’Malley, S. S., McCance‐Katz, E. F., Gordon, L. T., & Rounsaville, B. J. (1993) · American Journal on Addictions · doi:10.3109/10550499309115944 · Cited by 83
Disulfiram effects on responses to intravenous cocaine administration
Baker, J. R., Jatlow, P. I., & McCance‐Katz, E. F. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.016 · Cited by 77
Milligan, C. O., Nich, C., & Carroll, K. M. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.2.167 · Cited by 77
Chronic disulfiram treatment effects on intranasal cocaine administration: Initial results
McCance‐Katz, E. F., Kosten, T. R., & Jatlow, P. I. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00506-4 · Cited by 72
General Versus Systematic Inquiry about Emergent Clinical Events with SAFTEE
Rabkin, J. G., Markowitz, J. S., OCEPEK-WELIKSON, K., & Wager, S. (1992) · Current Opinion in Cardiology · doi:10.1097/00001573-199202000-00002 · Cited by 67
General Versus Systematic Inquiry about Emergent Clinical Events with SAFTEE
Rabkin, J. G., Markowitz, J. S., OCEPEK-WELIKSON, K., & Wager, S. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00002 · Cited by 60
Anticonvulsants for alcohol withdrawal
Polycarpou, A., Papanikolau, P., Ioannidis, J. P. A., & Contopoulos‐Ioannidis, D. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005064.pub2 · Cited by 55
Malcolm, R. J., Olive, M. F., & Lechner, W. V. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.4.459 · Cited by 52
Visual analogue scales and drug effects in man [editorial]
Nicholson, A. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb01673.x · Cited by 48
Cambio de los problemas de salud provocados por la cocaína en Cataluña
Suelves, J. M., Brugal, M. T., Caylà, J. A., & Torralba, L. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72184-7 · Cited by 45
Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats
Haile, C. N., During, M. J., Jatlow, P. I., Kosten, T. R., & Kosten, T. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00241-5 · Cited by 44
Grassi, M., Cioce, A., Giudici, F., Antonilli, L., & Nencini, P. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.005 · Cited by 43
Antipsychotic medications for cocaine dependence
Amato, L., Minozzi, S., Pani, P. P., & Davoli, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006306.pub2 · Cited by 26
Self-citationCost effectiveness of disulfiram
Jofre‐Bonet, M., Sindelar, J. L., Petrakis, I. L., Nich, C., Frankforter, T. L., Rounsaville, B. J., & Carroll, K. M. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(04)00004-2 · Cited by 23
Recreational drug consumers: who seeks treatment?
Siliquini, R., Morra, A., Versino, E., & Renga, G. (2005) · European Journal of Public Health · doi:10.1093/eurpub/cki031 · Cited by 20
Easton, C. J., Babuscio, T. A., & Carroll, K. M. (2007) · PubMed · Cited by 19
Research works printed but not linked: 19
- Carroll, 1998, Treatment for cocaine and alcohol dependence with psychotherapy and disulfiram, Addiction, 93, 713, 10.1046/j.1360-0443.1998.9357137.x · DOI · Paper page
- Carroll, 2004, Efficacy of Disulfiram and cognitive behavioral therapy in cocaine-dependent outpatients, Archives General Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
- Grassi, 2007, Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study, Pharmacol Res, 55, 117, 10.1016/j.phrs.2006.11.005 · DOI
- Pettinati, 2008, A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence, Addict Behav, 33, 651, 10.1016/j.addbeh.2007.11.011 · DOI · Paper page
- McCance EF Kosten TR Hameedi F Jatlow P Disulfiram treatment of cocaine abuse; findings from a dose-response study NIDA Research Monograph. Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting, the College on Problems of Drug Dependence, Inc Rockville, MD U.S. Department of Health and Human Services, National Institute on Drug Abuse 1997 138
- Baker, 2007, Disulfiram effects on responses to intravenous cocaine administration, Drug and Alcohol Dependence, 87, 202, 10.1016/j.drugalcdep.2006.08.016 · DOI
- Carroll, 1998, Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram, Addiction, 93, 713, 10.1046/j.1360-0443.1998.9357137.x · DOI · Paper page
- Carroll, 2000, One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment, Addiction, 95, 1335, 10.1046/j.1360-0443.2000.95913355.x · DOI · Paper page
- Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomised placebo-controlled trial, Archives of General Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
- Davoli, 2007, Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, 1996-2003: transition from heroin to cocaine use, European Addiction Research, 13, 185, 10.1159/000104880 · doi:10.1159/000104880
- First, 1995, Structured Clinical Interview for DSM-IV, Patient Edition
- George, 2000, Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial, Biological Psychiatry, 47, 1080, 10.1016/S0006-3223(99)00310-8 · DOI · Paper page
- Grassi, 2007 Feb, Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study, Pharmacological Research, 55, 117, 10.1016/j.phrs.2006.11.005 · DOI
- Karch, 2006, A Brief History of Cocaine
- McCance-Katz, 1998, Disulfiram effects on acute cocaine administration, Drug and Alcohol Dependce, 52, 27, 10.1016/S0376-8716(98)00050-7 · DOI
- McCance-Katz, 1998, Chronic disulfiram treatment effects on intranasal cocaine administration: initial results, Biological Psychiatry, 43, 540, 10.1016/S0006-3223(97)00506-4 · DOI
- Petrakis, 2000, Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts, Addiction, 95, 219, 10.1046/j.1360-0443.2000.9522198.x · DOI · Paper page
- Sorensen, 1991, Preventing AIDS in drug abusers and their sexual partners
- Spitzer, 1990, Structured Clinical Interview for DSM-III-R, Patient Edition/Non-patient Edition,(SCID-P/SCID-NP)
Cited by
Luchenski, S., Maguire, N., Aldridge, R. W., Hayward, A., Story, A., Perri, P., Withers, J., Clint, S., Fitzpatrick, S., & Hewett, N. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31959-1 · Cited by 430
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
“Disulfiram unexpectedly embarked upon a new career in the cocaine dependence treatment field [52].”
BackgroundSex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis
Becker, J. B., Perry, A. N., & Westenbroek, C. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-14 · Cited by 317
Degenhardt, L., Glantz, M., Evans‐Lacko, S., Sadikova, E., Sampson, N., Thornicroft, G., Aguilar‐Gaxiola, S., Al‐Hamzawi, A., Alonso, J., Helena Andrade, L., et al. (2017) · World Psychiatry · doi:10.1002/wps.20457 · Cited by 267
Treatment of stimulant use disorder: A systematic review of reviews
Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234809 · Cited by 222
Metadata
- Authors
- Pani, P. P., Trogu, E., Vacca, R., Amato, L., Vecchi, S., & Davoli, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-01-20
- Issue
- 1
- Pages
- CD007024-CD007024
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1999482407
- Cited by
- 255
- References
- 58
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Update notices
- new_version (2024-01-05)
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.